Weiss Asset Management LP Purchases New Stake in National Health Investors, Inc. $NHI

Weiss Asset Management LP purchased a new position in shares of National Health Investors, Inc. (NYSE:NHI) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund purchased 11,952 shares of the real estate investment trust’s stock, valued at approximately $966,000.

Other institutional investors and hedge funds have also modified their holdings of the company. International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the fourth quarter worth $27,000. EverSource Wealth Advisors LLC lifted its stake in National Health Investors by 244.1% in the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock valued at $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new position in National Health Investors in the fourth quarter valued at about $33,000. GAMMA Investing LLC boosted its holdings in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares during the last quarter. Finally, Key Capital Management INC bought a new position in National Health Investors during the fourth quarter worth about $47,000. 62.51% of the stock is owned by institutional investors.

Insider Buying and Selling at National Health Investors

In related news, Director Robert A. Mccabe, Jr. acquired 890 shares of the business’s stock in a transaction that occurred on Monday, June 15th. The shares were acquired at an average cost of $71.65 per share, with a total value of $63,768.50. Following the transaction, the director owned 44,159 shares of the company’s stock, valued at $3,163,992.35. The trade was a 2.06% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO D. Eric Mendelsohn bought 1,500 shares of National Health Investors stock in a transaction that occurred on Friday, June 5th. The stock was bought at an average cost of $68.84 per share, with a total value of $103,260.00. Following the completion of the purchase, the chief executive officer owned 133,316 shares in the company, valued at approximately $9,177,473.44. This trade represents a 1.14% increase in their position. The disclosure for this purchase is available in the SEC filing. 2.70% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

NHI has been the subject of a number of recent analyst reports. Weiss Ratings cut National Health Investors from a “buy (b)” rating to a “buy (b-)” rating in a research note on Friday, June 12th. Truist Financial reduced their price objective on shares of National Health Investors from $89.00 to $81.00 and set a “buy” rating on the stock in a research note on Friday, June 12th. Cantor Fitzgerald restated an “overweight” rating and set a $94.00 price objective on shares of National Health Investors in a report on Wednesday, April 22nd. BMO Capital Markets lowered their target price on shares of National Health Investors from $90.00 to $80.00 and set an “outperform” rating for the company in a research note on Monday, June 15th. Finally, Deutsche Bank Aktiengesellschaft cut their target price on shares of National Health Investors from $85.00 to $80.00 and set a “hold” rating on the stock in a report on Thursday, June 25th. Five equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, National Health Investors currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.86.

National Health Investors Price Performance

NYSE NHI opened at $79.23 on Tuesday. The company has a debt-to-equity ratio of 0.83, a quick ratio of 8.20 and a current ratio of 8.20. The stock has a market cap of $3.84 billion, a price-to-earnings ratio of 25.56, a PEG ratio of 3.62 and a beta of 0.51. The business has a 50 day simple moving average of $75.09 and a 200 day simple moving average of $79.76. National Health Investors, Inc. has a 52-week low of $67.94 and a 52-week high of $91.38.

National Health Investors Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 7th. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.92 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.68 annualized dividend and a dividend yield of 4.6%. National Health Investors’s dividend payout ratio is currently 118.71%.

National Health Investors Company Profile

National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.

Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.